przez Lord Kapucyn
21 sty 2014, 21:35
khaleesi, Proszę Cię, nie wklejaj jakichś banałów, które każdy wypowiadjący się w tym temacie zna.
-Treatment of Parkinson's disease (PD), either as monotherapy (without levodopa)) or in combination with L-DOPA therapy, in the early stages of the disease as well as in the advanced ones
-Treatment of pathological cognitive deficits in the elderly (impaired attention, motivation, memory, etc.)
-Treatment of dizziness in the elderly
-Treatment of retinal ischemic manifestations
-Adjunctive treatment of intermittent claudication due to peripheral vascular disease (PVD) of the lower limbs (stage 2)
-Adjunctive treatment of anhedonia and treatment-resistant depression in unipolar and bipolar depressives (off label)
-Treatment of gait disorders associated with Parkinson's disease (no related cause) and other forms of parkinsonism
The drug has been shown to enhance working memory capacities in normal aging adults.
Ogólnie o agonistach dopaminy-
Some medical drugs act as dopamine agonists and can treat hypodopaminergic (low dopamine) conditions; they are typically used for treating Parkinson's disease, attention deficit/hyperactivity disorder (in the form of stimulants) and certain pituitary tumors (prolactinoma), and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA-approved for the treatment of RLS. There is also an ongoing clinical trial to test the effectiveness of the dopamine agonist Requip (ropinirole) in reversing the symptoms of SSRI-induced sexual dysfunction and Post-SSRI sexual dysfunction (PSSD).
In age-related memory impairment, it has a positive effect on psychophysiological state of elderly people, improving memory and attention and increasing the velocity of psychomotor reactions and lability of nervous processes.
It enhances cognitive skill learning in healthy older adults.
It showed a positive effect in restless legs syndrome.
There is one wonder drug, but in three substances.
In the name of the stimulating N-(4-Bromophenyl)adamantan-2-amine,
and of the empathogenic (±)-4-Amino-3-phenyl-butyric acid,
and of the nootropic Ethyl 1-(phenylacetyl)-L-prolylglycinate.
"Jeżeli przysłucham się uważniej, słyszę jak moje geny łkają".